Diseases & Illness |

Osteonecrosis of the Jaw (ONJ) News

Osteonecrosis of the Jaw is Potential Risk of Biphosphonate Use

RSS News Feeds
Disease from Products
Osteonecrosis of the Jaw (ONJ)
Fosamax
 All RSS Feeds

At a glance:

This article concerns a study comparing two postmenopausal-osteoporosis medications, Boniva and Fosamax.
 
It showed that a larger percentage of women would tend to stay on treatment and thus retain some protection against bone fracture when taking only one pill a month (Boniva) than one pill a week (Fosamax).
 
Boniva belongs to the class of drugs known as biphosphonates, also used in cancer treatment, and one possible side effect recorded in cancer patients has been osteonecrosis of the jaw.

New Study Shows Women With Osteoporosis Preferred Once-Monthly ...

DG News - 3/17/2006 12:52 PM

Roche and GlaxoSmithKline (GSK) today announced results of an international study that demonstrates more than two-thirds (70%) of women with postmenopausal osteoporosis, who expressed a preference, preferred once-monthly dosing with Boniva(R) (ibandronate sodium) over weekly dosing with Fosamax(R) (alendronate sodium).(1)
 
In the study, the most common reason women gave for their preference was that one tablet a month is an easier treatment regimen to follow for a long period of time. Faced with no immediate symptoms from osteoporosis, half to almost two-thirds of women quit their daily or weekly osteoporosis medication wit
 
· Read The Full Osteonecrosis of the Jaw (ONJ) Article From DG News -->

· Read All Osteonecrosis of the Jaw (ONJ) News Stories -->

Comments On Osteonecrosis of the Jaw (ONJ) News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: